PT939613E - Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato - Google Patents

Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato

Info

Publication number
PT939613E
PT939613E PT97941536T PT97941536T PT939613E PT 939613 E PT939613 E PT 939613E PT 97941536 T PT97941536 T PT 97941536T PT 97941536 T PT97941536 T PT 97941536T PT 939613 E PT939613 E PT 939613E
Authority
PT
Portugal
Prior art keywords
phosphate
calcium
solution
overcare
ioes
Prior art date
Application number
PT97941536T
Other languages
English (en)
Inventor
Erling Johansen
Thor Olsen
Athena Papas
Original Assignee
Erling Johansen
Thor Olsen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9619464.2A external-priority patent/GB9619464D0/en
Application filed by Erling Johansen, Thor Olsen filed Critical Erling Johansen
Publication of PT939613E publication Critical patent/PT939613E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Biotechnology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97941536T 1996-09-18 1997-09-18 Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato PT939613E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2657896P 1996-09-18 1996-09-18
GBGB9619464.2A GB9619464D0 (en) 1996-09-18 1996-09-18 Compositions

Publications (1)

Publication Number Publication Date
PT939613E true PT939613E (pt) 2003-07-31

Family

ID=26310059

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97941536T PT939613E (pt) 1996-09-18 1997-09-18 Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato

Country Status (13)

Country Link
US (3) US5993785A (pt)
EP (1) EP0939613B1 (pt)
JP (2) JP3895388B2 (pt)
AT (1) ATE238761T1 (pt)
AU (1) AU4342497A (pt)
CA (1) CA2266409C (pt)
DE (1) DE69721556T2 (pt)
DK (1) DK0939613T3 (pt)
ES (1) ES2197364T3 (pt)
GB (1) GB2318977B (pt)
NO (1) NO313367B1 (pt)
PT (1) PT939613E (pt)
WO (1) WO1998011866A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI980051A1 (it) * 1998-03-06 1999-09-06 Italmed Di Galli Giovanna E Pa Composizione ad uso odontoiatrico per la desensibilizzazione della dentina esposta
NL1018208C2 (nl) * 2001-06-05 2002-12-10 Calcio B V Tandpasta.
TWI231182B (en) * 2001-12-11 2005-04-21 Shinkatsu Morisawa The effect of a buffering agent on acidogenesis of plaque
EP1607005B1 (en) * 2001-12-11 2008-10-08 Xiao Bing Wang The effect of a buffering agent on acidogenesis of plaque
CN1803147B (zh) * 2001-12-11 2010-08-04 王小兵 缓冲剂对牙菌斑酸化的作用
US6610275B1 (en) * 2002-02-13 2003-08-26 Joseph L. Owades Device for treating drinking water to make it hostile to dental plaque
US9011823B2 (en) 2005-02-01 2015-04-21 Ada Foundation Enhanced anti-carious dentifrices, rinses, lozenges, candies and chewing gums and methods of using same
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
EP2164512A2 (en) * 2007-06-20 2010-03-24 Actogenix N.V. Methods and compositions for treating mucositis
WO2009146104A1 (en) 2008-04-02 2009-12-03 Accentia Biopharmaceuticals, Inc. Formulations, devices and methods for treating and preventing mucositis
US20110086108A1 (en) * 2009-10-12 2011-04-14 Bartholomew Weldon Dissolving powders that can be mixed with water and used as an oral rinse
WO2011109919A1 (en) 2010-03-09 2011-09-15 Unilever Plc Stable oral care compositions
WO2012135426A2 (en) * 2011-03-29 2012-10-04 New York University Anti-bacterial and mineralizing calcium phosphate compositions
WO2012156502A2 (en) * 2011-05-18 2012-11-22 Arcoral Pharma As Two component mouth rinse preparation
HUE039577T2 (hu) 2011-06-01 2019-01-28 Intrexon Actobiotics Nv Policisztronos expressziós rendszer baktériumokhoz
IN2015DN03929A (pt) 2012-11-16 2015-10-02 Arcoral Pharma As
WO2015013549A1 (en) 2013-07-25 2015-01-29 Invado Pharmaceuticals, LLC Treating oral inflammation, injury or pain
JP5764712B1 (ja) * 2014-12-16 2015-08-19 株式会社松風 歯質再生剤
US11590165B2 (en) * 2014-12-17 2023-02-28 Bausch Health Companies Inc. Formulations of calcium and phosphate for oral inflammation
KR20180073612A (ko) * 2015-10-26 2018-07-02 콜게이트-파아므올리브캄파니 구강 관리 제품 및 방법
US10524993B2 (en) 2015-11-19 2020-01-07 Fantarella & Harewood, Llc Mouthwash composition
EP3402499B1 (en) 2016-01-14 2021-07-21 Intrexon Actobiotics NV Compositions and methods for the treatment of type 1 diabetes
CN109310587A (zh) * 2016-04-28 2019-02-05 加利福尼亚大学董事会 用于控制菌斑形成的组合物
CN109843320A (zh) 2016-09-02 2019-06-04 英特瑞克斯顿阿克图比奥帝克斯有限公司 稳定表达il-10和胰岛素的遗传修饰的细菌
RU2021135949A (ru) 2016-09-13 2022-04-14 Интрексон Актобиотикс Н.В. Мукоадгезивный микроорганизм
ES2933810T3 (es) * 2017-04-25 2023-02-14 Nutreco Ip Assets Bv Composición que contiene una sal de cloruro para uso en animales preñados
US11642199B2 (en) * 2018-09-24 2023-05-09 3M Innovative Properties Company Dental appliance with cosmetic therapeutic aqueous solution
CN114761028A (zh) 2019-09-27 2022-07-15 英特瑞克斯顿阿克图比奥帝克斯有限公司 乳糜泻的治疗
US11903992B2 (en) * 2021-01-23 2024-02-20 Cellix Bio Private Limited Composition comprising lidocaine, l-carnosine and dexpanthenol

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492247A1 (de) * 1964-03-20 1969-11-06 Warner Lambert Pharmaceutical Verfahren zum Wiederverhaerten von Zahnschmelz und dafuer geeignetes Zahnpflegemittel
US3679360A (en) * 1970-06-26 1972-07-25 Nasa Process for the preparation of brushite crystals
GB1408922A (en) * 1972-02-02 1975-10-08 Blendax Werke Schneider Co Process and composition for the remineralisation and prevention of demineralisation of human teeth
US4108980A (en) * 1973-01-11 1978-08-22 Colgate-Palmolive Company Process of preparing materials having calcium and phosphate components
US4048300A (en) * 1973-01-11 1977-09-13 Colgate-Palmolive Company Dental preparation containing materials having calcium and phosphate components
DE2452969A1 (de) * 1973-11-13 1975-05-15 Procter & Gamble Mittel zum remineralisieren von zahnschmelz
US4080440A (en) * 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4097588A (en) * 1975-03-11 1978-06-27 National Research Development Corporation Mineralizing dental mouthrinse
US4083955A (en) * 1975-04-02 1978-04-11 The Procter & Gamble Company Processes and compositions for remineralization of dental enamel
GB1509977A (en) * 1975-10-31 1978-05-10 Nat Res Dev Remineralising composition
US4097935A (en) * 1976-07-21 1978-07-04 Sterling Drug Inc. Hydroxylapatite ceramic
US4177258A (en) * 1978-10-13 1979-12-04 Colgate Palmolive Company Dentifrice for dental remineralization
US4183915A (en) * 1978-10-13 1980-01-15 Colgate-Palmolive Company Stable solution for dental remineralization
US4348381A (en) * 1981-05-06 1982-09-07 Colgate-Palmolive Company Dental remineralization composition
US4606912A (en) * 1981-07-22 1986-08-19 Caries Research Group Of Rochester, Inc. Method of making a clear, stable aqueous mouthwash solution and the solution made by that method for the enhancement of cells of the oral cavity and the remineralization of teeth
US4532124A (en) * 1981-08-19 1985-07-30 Development Finance Corporation Of New Zealand Dental rinse
US5037639A (en) * 1989-05-24 1991-08-06 American Dental Association Health Foundation Methods and compositions for mineralizing calcified tissues
US5460803A (en) * 1989-05-24 1995-10-24 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5427768A (en) * 1993-06-23 1995-06-27 American Dental Association Health Foundation Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use
US5658554A (en) 1995-06-01 1997-08-19 Colgate-Palmolive Company Mouth moistener for the relief of dry mouth condition
US5605675A (en) * 1995-06-06 1997-02-25 Enamelon Inc. Processes and compositions for remineralization and prevention of demineralization of dental enamel
US5603922A (en) * 1995-08-08 1997-02-18 Enamelon Inc. Processes and compositions for the remineralization of teeth
US5571502A (en) * 1995-08-08 1996-11-05 Enamelon Research Stable single-part compositions and the use thereof for remineralization of lesions in teeth

Also Published As

Publication number Publication date
DK0939613T3 (da) 2003-07-14
JP2006199702A (ja) 2006-08-03
JP4746441B2 (ja) 2011-08-10
EP0939613B1 (en) 2003-05-02
DE69721556T2 (de) 2004-03-04
US5993785A (en) 1999-11-30
DE69721556D1 (de) 2003-06-05
CA2266409C (en) 2009-01-06
EP0939613A1 (en) 1999-09-08
JP3895388B2 (ja) 2007-03-22
US20030152530A1 (en) 2003-08-14
NO991302L (no) 1999-03-17
NO313367B1 (no) 2002-09-23
ES2197364T3 (es) 2004-01-01
CA2266409A1 (en) 1998-03-26
NO991302D0 (no) 1999-03-17
JP2001500874A (ja) 2001-01-23
WO1998011866A1 (en) 1998-03-26
US6387352B1 (en) 2002-05-14
AU4342497A (en) 1998-04-14
ATE238761T1 (de) 2003-05-15
GB9719780D0 (en) 1997-11-19
GB2318977A (en) 1998-05-13
GB2318977B (en) 1999-07-21
US20020044910A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
PT939613E (pt) Solucao sobressaturada para lavagem bucal contendo ioes calcio e fosfato
SE8201086L (sv) Dental remineraliseringskomposition
SE7905790L (sv) Stabil komposition for dental remineralisering
FI952110A0 (fi) Remineralisoiva hammashoitoaine
ATE164310T1 (de) Dentale schale
EP1682030A4 (en) METHODS OF TREATING DENTAL CONDITIONS USING TISSUE MEDIA
GR3018468T3 (en) Methods for treating teeth surfaces.
BRPI0413566A (pt) composição de branqueamento de dentes, e, métodos de branqueamento de uma superfìcie de um dente em um cavidade oral de um paciente e de branqueamento de um dente em um mamìfero
IL137012A0 (en) Preparation for dental treatment
DE69008153D1 (de) Mundwasser und verfahren zur beseitigung des zahnsteins.
Wefel et al. In vitro evaluation of fluoride uptake from a thixotropic gel
SE9504259D0 (sv) Method and composition for removal of mercury released from amalgam in the oral cavity
JP2009242290A (ja) 歯牙漂白用組成物
DE60217857D1 (de) Remineralisierende zahnhygieneprodukte
WO2023159244A3 (en) Treatment and prevention of dental demineralization
Pimenta COMMENTARY. bleaching agents with varying concentrations of carbamide and/or hydrogen peroxides: effect on dental microhardness and roughness.
AR011477A1 (es) Un producto liquido, una composicion acuosa mezclada y un metodo para la remineralizacion de lesiones subsuperficiales y/o mineralizacion detubuladoras en la dentina expuesta de dientes y un producto envasado de dos componentes.